Acta Pharmaceutica Sinica B-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2219363, encodeId=8e0222193631d, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Sat Aug 10 09:06:24 CST 2024, time=25分钟前, status=0, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2219346, encodeId=f5f6221934678, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Aug 10 01:37:51 CST 2024, time=7小时前, status=0, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198858, encodeId=5ad1219885811, content=23.7.25 投稿；23.9.15大修；23.10.10修回；23.12.20接收 总的来讲除了效率较慢是一次愉快的投稿。接收后见刊较慢，需要文章见刊才能毕业的慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Apr 16 21:11:51 CST 2024, time=2024-04-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2205607, encodeId=4a7e220560e16, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：一审时间两个月，两个审稿人小修，一个大修。给了两个月的时间，修回后，二审又快两个月了，还在外审。。。着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=ms3000000749699706, createdTime=Mon May 20 09:31:46 CST 2024, time=2024-05-20, status=1, ipAttribution=广东), GetPortalCommentsPageByObjectIdResponse(id=2104697, encodeId=da94210469ea6, content=一审一个月，修回后很快under review，现在快两个月了状态都没变，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c08110505, createdName=ms6000000900212273, createdTime=Wed Dec 07 09:39:03 CST 2022, time=2022-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200026, encodeId=31b7220002650, content=审稿速度:1.0 偏重的研究方向：肺血管 经验分享：4.4 submitted 4.6 with editor 4.10 rejected, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75949069147, createdName=ms3000002136837137, createdTime=Tue Apr 23 20:51:34 CST 2024, time=2024-04-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198332, encodeId=fb0a21983329b, content=偏重的研究方向：生物 经验分享：圈子期刊，通常是大佬们10+文章的最后选择之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Apr 13 22:33:34 CST 2024, time=2024-04-13, status=1, ipAttribution=安徽省)]

25分钟前 121b8024m37(暂无昵称) 来自河南省

前往app查看评论内容

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2219363, encodeId=8e0222193631d, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Sat Aug 10 09:06:24 CST 2024, time=25分钟前, status=0, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2219346, encodeId=f5f6221934678, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Aug 10 01:37:51 CST 2024, time=7小时前, status=0, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198858, encodeId=5ad1219885811, content=23.7.25 投稿；23.9.15大修；23.10.10修回；23.12.20接收 总的来讲除了效率较慢是一次愉快的投稿。接收后见刊较慢，需要文章见刊才能毕业的慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Apr 16 21:11:51 CST 2024, time=2024-04-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2205607, encodeId=4a7e220560e16, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：一审时间两个月，两个审稿人小修，一个大修。给了两个月的时间，修回后，二审又快两个月了，还在外审。。。着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=ms3000000749699706, createdTime=Mon May 20 09:31:46 CST 2024, time=2024-05-20, status=1, ipAttribution=广东), GetPortalCommentsPageByObjectIdResponse(id=2104697, encodeId=da94210469ea6, content=一审一个月，修回后很快under review，现在快两个月了状态都没变，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c08110505, createdName=ms6000000900212273, createdTime=Wed Dec 07 09:39:03 CST 2022, time=2022-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200026, encodeId=31b7220002650, content=审稿速度:1.0 偏重的研究方向：肺血管 经验分享：4.4 submitted 4.6 with editor 4.10 rejected, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75949069147, createdName=ms3000002136837137, createdTime=Tue Apr 23 20:51:34 CST 2024, time=2024-04-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198332, encodeId=fb0a21983329b, content=偏重的研究方向：生物 经验分享：圈子期刊，通常是大佬们10+文章的最后选择之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Apr 13 22:33:34 CST 2024, time=2024-04-13, status=1, ipAttribution=安徽省)]

7小时前 ms6000002140643083 来自安徽省

前往app查看评论内容

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2219363, encodeId=8e0222193631d, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Sat Aug 10 09:06:24 CST 2024, time=25分钟前, status=0, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2219346, encodeId=f5f6221934678, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Aug 10 01:37:51 CST 2024, time=7小时前, status=0, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198858, encodeId=5ad1219885811, content=23.7.25 投稿；23.9.15大修；23.10.10修回；23.12.20接收 总的来讲除了效率较慢是一次愉快的投稿。接收后见刊较慢，需要文章见刊才能毕业的慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Apr 16 21:11:51 CST 2024, time=2024-04-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2205607, encodeId=4a7e220560e16, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：一审时间两个月，两个审稿人小修，一个大修。给了两个月的时间，修回后，二审又快两个月了，还在外审。。。着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=ms3000000749699706, createdTime=Mon May 20 09:31:46 CST 2024, time=2024-05-20, status=1, ipAttribution=广东), GetPortalCommentsPageByObjectIdResponse(id=2104697, encodeId=da94210469ea6, content=一审一个月，修回后很快under review，现在快两个月了状态都没变，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c08110505, createdName=ms6000000900212273, createdTime=Wed Dec 07 09:39:03 CST 2022, time=2022-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200026, encodeId=31b7220002650, content=审稿速度:1.0 偏重的研究方向：肺血管 经验分享：4.4 submitted 4.6 with editor 4.10 rejected, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75949069147, createdName=ms3000002136837137, createdTime=Tue Apr 23 20:51:34 CST 2024, time=2024-04-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198332, encodeId=fb0a21983329b, content=偏重的研究方向：生物 经验分享：圈子期刊，通常是大佬们10+文章的最后选择之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Apr 13 22:33:34 CST 2024, time=2024-04-13, status=1, ipAttribution=安徽省)]

2023-07-25 Mr.Curiosity 来自安徽省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：生物;药理
经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久

96 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219363, encodeId=8e0222193631d, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Sat Aug 10 09:06:24 CST 2024, time=25分钟前, status=0, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2219346, encodeId=f5f6221934678, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Aug 10 01:37:51 CST 2024, time=7小时前, status=0, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198858, encodeId=5ad1219885811, content=23.7.25 投稿；23.9.15大修；23.10.10修回；23.12.20接收 总的来讲除了效率较慢是一次愉快的投稿。接收后见刊较慢，需要文章见刊才能毕业的慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Apr 16 21:11:51 CST 2024, time=2024-04-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2205607, encodeId=4a7e220560e16, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：一审时间两个月，两个审稿人小修，一个大修。给了两个月的时间，修回后，二审又快两个月了，还在外审。。。着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=ms3000000749699706, createdTime=Mon May 20 09:31:46 CST 2024, time=2024-05-20, status=1, ipAttribution=广东), GetPortalCommentsPageByObjectIdResponse(id=2104697, encodeId=da94210469ea6, content=一审一个月，修回后很快under review，现在快两个月了状态都没变，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c08110505, createdName=ms6000000900212273, createdTime=Wed Dec 07 09:39:03 CST 2022, time=2022-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200026, encodeId=31b7220002650, content=审稿速度:1.0 偏重的研究方向：肺血管 经验分享：4.4 submitted 4.6 with editor 4.10 rejected, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75949069147, createdName=ms3000002136837137, createdTime=Tue Apr 23 20:51:34 CST 2024, time=2024-04-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198332, encodeId=fb0a21983329b, content=偏重的研究方向：生物 经验分享：圈子期刊，通常是大佬们10+文章的最后选择之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Apr 13 22:33:34 CST 2024, time=2024-04-13, status=1, ipAttribution=安徽省)]

2024-07-03 科研~菜鸟来自河南省

审稿速度:2.0
偏重的研究方向：肿瘤
经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？

25 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219363, encodeId=8e0222193631d, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Sat Aug 10 09:06:24 CST 2024, time=25分钟前, status=0, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2219346, encodeId=f5f6221934678, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Aug 10 01:37:51 CST 2024, time=7小时前, status=0, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198858, encodeId=5ad1219885811, content=23.7.25 投稿；23.9.15大修；23.10.10修回；23.12.20接收 总的来讲除了效率较慢是一次愉快的投稿。接收后见刊较慢，需要文章见刊才能毕业的慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Apr 16 21:11:51 CST 2024, time=2024-04-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2205607, encodeId=4a7e220560e16, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：一审时间两个月，两个审稿人小修，一个大修。给了两个月的时间，修回后，二审又快两个月了，还在外审。。。着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=ms3000000749699706, createdTime=Mon May 20 09:31:46 CST 2024, time=2024-05-20, status=1, ipAttribution=广东), GetPortalCommentsPageByObjectIdResponse(id=2104697, encodeId=da94210469ea6, content=一审一个月，修回后很快under review，现在快两个月了状态都没变，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c08110505, createdName=ms6000000900212273, createdTime=Wed Dec 07 09:39:03 CST 2022, time=2022-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200026, encodeId=31b7220002650, content=审稿速度:1.0 偏重的研究方向：肺血管 经验分享：4.4 submitted 4.6 with editor 4.10 rejected, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75949069147, createdName=ms3000002136837137, createdTime=Tue Apr 23 20:51:34 CST 2024, time=2024-04-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198332, encodeId=fb0a21983329b, content=偏重的研究方向：生物 经验分享：圈子期刊，通常是大佬们10+文章的最后选择之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Apr 13 22:33:34 CST 2024, time=2024-04-13, status=1, ipAttribution=安徽省)]

2024-04-16 ms8000000053730142 来自江苏省

23.7.25 投稿；23.9.15大修；23.10.10修回；23.12.20接收
总的来讲除了效率较慢是一次愉快的投稿。接收后见刊较慢，需要文章见刊才能毕业的慎重

71 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219363, encodeId=8e0222193631d, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Sat Aug 10 09:06:24 CST 2024, time=25分钟前, status=0, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2219346, encodeId=f5f6221934678, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Aug 10 01:37:51 CST 2024, time=7小时前, status=0, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198858, encodeId=5ad1219885811, content=23.7.25 投稿；23.9.15大修；23.10.10修回；23.12.20接收 总的来讲除了效率较慢是一次愉快的投稿。接收后见刊较慢，需要文章见刊才能毕业的慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Apr 16 21:11:51 CST 2024, time=2024-04-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2205607, encodeId=4a7e220560e16, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：一审时间两个月，两个审稿人小修，一个大修。给了两个月的时间，修回后，二审又快两个月了，还在外审。。。着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=ms3000000749699706, createdTime=Mon May 20 09:31:46 CST 2024, time=2024-05-20, status=1, ipAttribution=广东), GetPortalCommentsPageByObjectIdResponse(id=2104697, encodeId=da94210469ea6, content=一审一个月，修回后很快under review，现在快两个月了状态都没变，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c08110505, createdName=ms6000000900212273, createdTime=Wed Dec 07 09:39:03 CST 2022, time=2022-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200026, encodeId=31b7220002650, content=审稿速度:1.0 偏重的研究方向：肺血管 经验分享：4.4 submitted 4.6 with editor 4.10 rejected, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75949069147, createdName=ms3000002136837137, createdTime=Tue Apr 23 20:51:34 CST 2024, time=2024-04-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198332, encodeId=fb0a21983329b, content=偏重的研究方向：生物 经验分享：圈子期刊，通常是大佬们10+文章的最后选择之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Apr 13 22:33:34 CST 2024, time=2024-04-13, status=1, ipAttribution=安徽省)]

2024-05-20 ms3000000749699706 来自广东

审稿速度:2.0
偏重的研究方向：肿瘤
经验分享：一审时间两个月，两个审稿人小修，一个大修。给了两个月的时间，修回后，二审又快两个月了，还在外审。。。着急啊

70 0

[GetPortalCommentsPageByObjectIdResponse(id=2219363, encodeId=8e0222193631d, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Sat Aug 10 09:06:24 CST 2024, time=25分钟前, status=0, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2219346, encodeId=f5f6221934678, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Aug 10 01:37:51 CST 2024, time=7小时前, status=0, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198858, encodeId=5ad1219885811, content=23.7.25 投稿；23.9.15大修；23.10.10修回；23.12.20接收 总的来讲除了效率较慢是一次愉快的投稿。接收后见刊较慢，需要文章见刊才能毕业的慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Apr 16 21:11:51 CST 2024, time=2024-04-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2205607, encodeId=4a7e220560e16, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：一审时间两个月，两个审稿人小修，一个大修。给了两个月的时间，修回后，二审又快两个月了，还在外审。。。着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=ms3000000749699706, createdTime=Mon May 20 09:31:46 CST 2024, time=2024-05-20, status=1, ipAttribution=广东), GetPortalCommentsPageByObjectIdResponse(id=2104697, encodeId=da94210469ea6, content=一审一个月，修回后很快under review，现在快两个月了状态都没变，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c08110505, createdName=ms6000000900212273, createdTime=Wed Dec 07 09:39:03 CST 2022, time=2022-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200026, encodeId=31b7220002650, content=审稿速度:1.0 偏重的研究方向：肺血管 经验分享：4.4 submitted 4.6 with editor 4.10 rejected, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75949069147, createdName=ms3000002136837137, createdTime=Tue Apr 23 20:51:34 CST 2024, time=2024-04-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198332, encodeId=fb0a21983329b, content=偏重的研究方向：生物 经验分享：圈子期刊，通常是大佬们10+文章的最后选择之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Apr 13 22:33:34 CST 2024, time=2024-04-13, status=1, ipAttribution=安徽省)]

2022-12-07 ms6000000900212273 来自江苏省

一审一个月，修回后很快under review，现在快两个月了状态都没变，还要多久啊

114 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219363, encodeId=8e0222193631d, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Sat Aug 10 09:06:24 CST 2024, time=25分钟前, status=0, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2219346, encodeId=f5f6221934678, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Aug 10 01:37:51 CST 2024, time=7小时前, status=0, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198858, encodeId=5ad1219885811, content=23.7.25 投稿；23.9.15大修；23.10.10修回；23.12.20接收 总的来讲除了效率较慢是一次愉快的投稿。接收后见刊较慢，需要文章见刊才能毕业的慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Apr 16 21:11:51 CST 2024, time=2024-04-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2205607, encodeId=4a7e220560e16, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：一审时间两个月，两个审稿人小修，一个大修。给了两个月的时间，修回后，二审又快两个月了，还在外审。。。着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=ms3000000749699706, createdTime=Mon May 20 09:31:46 CST 2024, time=2024-05-20, status=1, ipAttribution=广东), GetPortalCommentsPageByObjectIdResponse(id=2104697, encodeId=da94210469ea6, content=一审一个月，修回后很快under review，现在快两个月了状态都没变，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c08110505, createdName=ms6000000900212273, createdTime=Wed Dec 07 09:39:03 CST 2022, time=2022-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200026, encodeId=31b7220002650, content=审稿速度:1.0 偏重的研究方向：肺血管 经验分享：4.4 submitted 4.6 with editor 4.10 rejected, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75949069147, createdName=ms3000002136837137, createdTime=Tue Apr 23 20:51:34 CST 2024, time=2024-04-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198332, encodeId=fb0a21983329b, content=偏重的研究方向：生物 经验分享：圈子期刊，通常是大佬们10+文章的最后选择之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Apr 13 22:33:34 CST 2024, time=2024-04-13, status=1, ipAttribution=安徽省)]

2024-04-23 ms3000002136837137 来自浙江省

审稿速度:1.0
偏重的研究方向：肺血管
经验分享：4.4 submitted 4.6 with editor 4.10 rejected

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219363, encodeId=8e0222193631d, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Sat Aug 10 09:06:24 CST 2024, time=25分钟前, status=0, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2219346, encodeId=f5f6221934678, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Aug 10 01:37:51 CST 2024, time=7小时前, status=0, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198858, encodeId=5ad1219885811, content=23.7.25 投稿；23.9.15大修；23.10.10修回；23.12.20接收 总的来讲除了效率较慢是一次愉快的投稿。接收后见刊较慢，需要文章见刊才能毕业的慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Apr 16 21:11:51 CST 2024, time=2024-04-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2205607, encodeId=4a7e220560e16, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：一审时间两个月，两个审稿人小修，一个大修。给了两个月的时间，修回后，二审又快两个月了，还在外审。。。着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=ms3000000749699706, createdTime=Mon May 20 09:31:46 CST 2024, time=2024-05-20, status=1, ipAttribution=广东), GetPortalCommentsPageByObjectIdResponse(id=2104697, encodeId=da94210469ea6, content=一审一个月，修回后很快under review，现在快两个月了状态都没变，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c08110505, createdName=ms6000000900212273, createdTime=Wed Dec 07 09:39:03 CST 2022, time=2022-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200026, encodeId=31b7220002650, content=审稿速度:1.0 偏重的研究方向：肺血管 经验分享：4.4 submitted 4.6 with editor 4.10 rejected, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75949069147, createdName=ms3000002136837137, createdTime=Tue Apr 23 20:51:34 CST 2024, time=2024-04-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198332, encodeId=fb0a21983329b, content=偏重的研究方向：生物 经验分享：圈子期刊，通常是大佬们10+文章的最后选择之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Apr 13 22:33:34 CST 2024, time=2024-04-13, status=1, ipAttribution=安徽省)]

2022-10-17 ms9000000615443695

为什么他们Decision in Process也很长时间啊！！！

105 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2219363, encodeId=8e0222193631d, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=faf92276694, createdName=121b8024m37(暂无昵称), createdTime=Sat Aug 10 09:06:24 CST 2024, time=25分钟前, status=0, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2219346, encodeId=f5f6221934678, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Aug 10 01:37:51 CST 2024, time=7小时前, status=0, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2149724, encodeId=9c952149e2440, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：生物;药理 经验分享：2月12日投稿，6月13日正式接收。正式接受后一个多月都没有出proof版本，请问一般这个杂志出proof要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8e7d2228833, createdName=Mr.Curiosity, createdTime=Tue Jul 25 11:41:51 CST 2023, time=2023-07-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2212910, encodeId=824c2212910f4, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：自从收到预接受文件满心欢喜。修回格式已经20天了，还没有收到正式接收的邮件，心里忐忑不安。。。。有没有朋友遇到同样情况的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=科研~菜鸟, createdTime=Wed Jul 03 08:54:51 CST 2024, time=2024-07-03, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2198858, encodeId=5ad1219885811, content=23.7.25 投稿；23.9.15大修；23.10.10修回；23.12.20接收 总的来讲除了效率较慢是一次愉快的投稿。接收后见刊较慢，需要文章见刊才能毕业的慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06645707969, createdName=ms8000000053730142, createdTime=Tue Apr 16 21:11:51 CST 2024, time=2024-04-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2205607, encodeId=4a7e220560e16, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：一审时间两个月，两个审稿人小修，一个大修。给了两个月的时间，修回后，二审又快两个月了，还在外审。。。着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=ed509121182, createdName=ms3000000749699706, createdTime=Mon May 20 09:31:46 CST 2024, time=2024-05-20, status=1, ipAttribution=广东), GetPortalCommentsPageByObjectIdResponse(id=2104697, encodeId=da94210469ea6, content=一审一个月，修回后很快under review，现在快两个月了状态都没变，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0c08110505, createdName=ms6000000900212273, createdTime=Wed Dec 07 09:39:03 CST 2022, time=2022-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200026, encodeId=31b7220002650, content=审稿速度:1.0 偏重的研究方向：肺血管 经验分享：4.4 submitted 4.6 with editor 4.10 rejected, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75949069147, createdName=ms3000002136837137, createdTime=Tue Apr 23 20:51:34 CST 2024, time=2024-04-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2094226, encodeId=6a6e20942265e, content=为什么他们Decision in Process也很长时间啊！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Mon Oct 17 15:06:43 CST 2022, time=2022-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2198332, encodeId=fb0a21983329b, content=偏重的研究方向：生物 经验分享：圈子期刊，通常是大佬们10+文章的最后选择之一。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Sat Apr 13 22:33:34 CST 2024, time=2024-04-13, status=1, ipAttribution=安徽省)]

2024-04-13 1811e984f8m 来自安徽省

偏重的研究方向：生物
经验分享：圈子期刊，通常是大佬们10+文章的最后选择之一。

68 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务